MME and myelodysplastic syndrome: Although considered diagnostic, cytogenetic analysis typically contributes to only 40% of cases, showing a variety of abnormalties.4 Consequently, scoring systems have been advocated for use in diagnosis to improve sensitivity and specificity of diagnosis.4,16 Various flow cytometric parameters have been evaluated as useful diagnostic indicators in MDS, including use of CD10 expression on granulocytic cells.21